Laboratory of Molecular Microbiology,
National Institute of Allergy and Infectious Diseases,
Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases
Malcolm A. Martin has not added Biography.
If you are Malcolm A. Martin and would like to personalize this page please email our Author Liaison for assistance.
Common methionine-tryptic peptides near the amino-terminal end of primate papovavirus tumor antigens.
Proceedings of the National Academy of Sciences of the United States of America Mar, 1978 | Pubmed ID: 206886
Physical and biochemical properties of progressive pneumonia virus.
Journal of virology Oct, 1971 | Pubmed ID: 4108574
SV40 gene activity during lytic infection and in a series of SV40 transformed mouse cells.
Proceedings of the National Academy of Sciences of the United States of America Dec, 1969 | Pubmed ID: 4318346
Detection and quantitation of simian virus 40 genetic material in abortively transformed BALB-3T3 clones (mice-diploid cells-virus equivalents).
Proceedings of the National Academy of Sciences of the United States of America Jan, 1972 | Pubmed ID: 4333038
Patterns of Simian Virus 40 DNA transcription after acute infection of permissive and nonpermissive cells.
Proceedings of the National Academy of Sciences of the United States of America Jul, 1972 | Pubmed ID: 4340164
Patterns of simian virus 40 deoxyribonucleic acid transcription. II. In transformed cells.
Journal of virology Jan, 1973 | Pubmed ID: 4346281
A general method of gene isolation.
Proceedings of the National Academy of Sciences of the United States of America Jun, 1973 | Pubmed ID: 4352649
In vitro transcription of the viral-specific sequences present in the chromatin of cells transformed by simian virus 40.
Proceedings of the National Academy of Sciences of the United States of America Dec, 1973 | Pubmed ID: 4357875
Reassortment of simian virus 40 DNA during serial undiluted passage.
Journal of virology Oct, 1973 | Pubmed ID: 4359951
Sedimentation properties of simian virus 40-specific ribonucleic acid present in green monkey cells during productive infection and in mouse cells undergoing abortive infection.
Journal of virology Oct, 1970 | Pubmed ID: 5497892
Administration of an anti-CD8 monoclonal antibody interferes with the clearance of chimeric simian/human immunodeficiency virus during primary infections of rhesus macaques.
Journal of virology Jan, 1998 | Pubmed ID: 9420212
Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Journal of virology Mar, 1998 | Pubmed ID: 9499115
Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter.
Molecular and cellular biology May, 1998 | Pubmed ID: 9566873
Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus.
Journal of virology Aug, 2000 | Pubmed ID: 10888632
Identification of gp120 regions targeted by a highly potent neutralizing antiserum elicited in a chimpanzee inoculated with a primary human immunodeficiency virus type 1 isolate.
Journal of virology Oct, 2000 | Pubmed ID: 11000249
Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans.
Proceedings of the National Academy of Sciences of the United States of America Jan, 2001 | Pubmed ID: 11136236
Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques.
Journal of virology Mar, 2001 | Pubmed ID: 11160726
N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
Journal of virology Jul, 2001 | Pubmed ID: 11390601
Rapid and irreversible CD4+ T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous.
Journal of virology Jan, 2002 | Pubmed ID: 11739702
Determination of a statistically valid neutralization titer in plasma that confers protection against simian-human immunodeficiency virus challenge following passive transfer of high-titered neutralizing antibodies.
Journal of virology Mar, 2002 | Pubmed ID: 11836389
Evolution of a human immunodeficiency virus type 1 variant with enhanced replication in pig-tailed macaque cells by DNA shuffling.
Journal of virology Mar, 2002 | Pubmed ID: 11861859
Amino acid deletions are introduced into the V2 region of gp120 during independent pathogenic simian immunodeficiency virus/HIV chimeric virus (SHIV) infections of rhesus monkeys generating variants that are macrophage tropic.
Proceedings of the National Academy of Sciences of the United States of America Oct, 2002 | Pubmed ID: 12370415
Control of viremia and prevention of simian-human immunodeficiency virus-induced disease in rhesus macaques immunized with recombinant vaccinia viruses plus inactivated simian immunodeficiency virus and human immunodeficiency virus type 1 particles.
Journal of virology Jan, 2003 | Pubmed ID: 12502833
Characterization of pig-tailed macaque classical MHC class I genes: implications for MHC evolution and antigen presentation in macaques.
Journal of immunology (Baltimore, Md. : 1950) Jul, 2003 | Pubmed ID: 12847257
Early control of highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys usually results in long-lasting asymptomatic clinical outcomes.
Journal of virology Oct, 2003 | Pubmed ID: 14512533
The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
Journal of leukocyte biology Nov, 2003 | Pubmed ID: 14595005
Transfer of neutralizing IgG to macaques 6 h but not 24 h after SHIV infection confers sterilizing protection: implications for HIV-1 vaccine development.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2003 | Pubmed ID: 14627745
Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
Journal of virology Dec, 2003 | Pubmed ID: 14645561
Induction of disease by a molecularly cloned highly pathogenic simian immunodeficiency virus/human immunodeficiency virus chimera is multigenic.
Journal of virology May, 2004 | Pubmed ID: 15113931
Pig-tailed macaques (Macaca nemestrina) possess six MHC-E families that are conserved among macaque species: implication for their binding to natural killer receptor variants.
Immunogenetics Jun, 2004 | Pubmed ID: 15148641
Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses.
Proceedings of the National Academy of Sciences of the United States of America Aug, 2004 | Pubmed ID: 15297611
Resting naive CD4+ T cells are massively infected and eliminated by X4-tropic simian-human immunodeficiency viruses in macaques.
Proceedings of the National Academy of Sciences of the United States of America May, 2005 | Pubmed ID: 15911767
CD8+ and CD20+ lymphocytes cooperate to control acute simian immunodeficiency virus/human immunodeficiency virus chimeric virus infections in rhesus monkeys: modulation by major histocompatibility complex genotype.
Journal of virology Dec, 2005 | Pubmed ID: 16282488
Generation of HIV-1 derivatives that productively infect macaque monkey lymphoid cells.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2006 | Pubmed ID: 17065315
Loss of naïve cells accompanies memory CD4+ T-cell depletion during long-term progression to AIDS in Simian immunodeficiency virus-infected macaques.
Journal of virology Jan, 2007 | Pubmed ID: 17093193
The locus encoding an oligomorphic family of MHC-A alleles (Mane-A*06/Mamu-A*05) is present at high frequency in several macaque species.
Immunogenetics Mar, 2007 | Pubmed ID: 17256149
Although macrophage-tropic simian/human immunodeficiency viruses can exhibit a range of pathogenic phenotypes, a majority of isolates induce no clinical disease in immunocompetent macaques.
Journal of virology Oct, 2007 | Pubmed ID: 17626082
Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.
Journal of virology Oct, 2007 | Pubmed ID: 17670817
Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response.
Journal of virology Nov, 2008 | Pubmed ID: 18768967
High frequencies of resting CD4+ T cells containing integrated viral DNA are found in rhesus macaques during acute lentivirus infections.
Proceedings of the National Academy of Sciences of the United States of America May, 2009 | Pubmed ID: 19416840
Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease.
Journal of virology Jul, 2009 | Pubmed ID: 19420078
Neutralizing antibody titers conferring protection to macaques from a simian/human immunodeficiency virus challenge using the TZM-bl assay.
AIDS research and human retroviruses Jan, 2010 | Pubmed ID: 20059398
Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.
Journal of virology May, 2010 | Pubmed ID: 20147396
Recombination-mediated changes in coreceptor usage confer an augmented pathogenic phenotype in a nonhuman primate model of HIV-1-induced AIDS.
Journal of virology Oct, 2011 | Pubmed ID: 21813599
The acute HIV infection: implications for intervention, prevention and development of an effective AIDS vaccine.
Current opinion in virology Sep, 2011 | Pubmed ID: 21909345
The simian immunodeficiency virus targets central cell cycle functions through transcriptional repression in vivo.
PloS one , 2011 | Pubmed ID: 22043290
Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque.
Proceedings of the National Academy of Sciences of the United States of America Dec, 2011 | Pubmed ID: 22123961
Pathogenicity and mucosal transmissibility of the R5-tropic simian/human immunodeficiency virus SHIV(AD8) in rhesus macaques: implications for use in vaccine studies.
Journal of virology Aug, 2012 | Pubmed ID: 22647691
Most rhesus macaques infected with the CCR5-tropic SHIV(AD8) generate cross-reactive antibodies that neutralize multiple HIV-1 strains.
Proceedings of the National Academy of Sciences of the United States of America Nov, 2012 | Pubmed ID: 23129652
Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization.
Science (New York, N.Y.) May, 2013 | Pubmed ID: 23661761
Emergence of gp120 V3 variants confers neutralization resistance in an R5 simian-human immunodeficiency virus-infected macaque elite neutralizer that targets the N332 glycan of the human immunodeficiency virus type 1 envelope glycoprotein.
Journal of virology Aug, 2013 | Pubmed ID: 23720719
Antibody-mediated immunotherapy of macaques chronically infected with SHIV suppresses viraemia.
Nature Nov, 2013 | Pubmed ID: 24172896
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques.
The Journal of experimental medicine Sep, 2014 | Pubmed ID: 25155019
Enhanced HIV-1 immunotherapy by commonly arising antibodies that target virus escape variants.
The Journal of experimental medicine Nov, 2014 | Pubmed ID: 25385756
Analysis of immunoglobulin transcripts and hypermutation following SHIV(AD8) infection and protein-plus-adjuvant immunization.
Nature communications , 2015 | Pubmed ID: 25858157
The Expression of Functional Vpx during Pathogenic SIVmac Infections of Rhesus Macaques Suppresses SAMHD1 in CD4+ Memory T Cells.
PLoS pathogens May, 2015 | Pubmed ID: 25996507
Quality and quantity of TFH cells are critical for broad antibody development in SHIVAD8 infection.
Science translational medicine Jul, 2015 | Pubmed ID: 26223303
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.
Nature May, 2016 | Pubmed ID: 27120156
DNA Prime-Boost Vaccine Regimen To Increase Breadth, Magnitude, and Cytotoxicity of the Cellular Immune Responses to Subdominant Gag Epitopes of Simian Immunodeficiency Virus and HIV.
Journal of immunology (Baltimore, Md. : 1950) Nov, 2016 | Pubmed ID: 27733554
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.
PLoS pathogens Jan, 2017 | Pubmed ID: 28052137
Early antibody therapy can induce long-lasting immunity to SHIV.
Nature Mar, 2017 | Pubmed ID: 28289286
Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.
Cell host & microbe Aug, 2017 | Pubmed ID: 28799906
Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections.
PLoS pathogens Mar, 2018 | Pubmed ID: 29505593
A single injection of crystallizable fragment domain-modified antibodies elicits durable protection from SHIV infection.
Nature medicine May, 2018 | Pubmed ID: 29662199
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques.
Nature Jun, 2019 | Pubmed ID: 31142836
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia.
The Journal of experimental medicine Jan, 2021 | Pubmed ID: 32966579
Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.
The Journal of clinical investigation Sep, 2021 | Pubmed ID: 34623326
Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope.
NPJ vaccines Oct, 2021 | Pubmed ID: 34697307
Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env.
Science translational medicine Nov, 2021 | Pubmed ID: 34818054
Neutralizing antibodies induced in immunized macaques recognize the CD4-binding site on an occluded-open HIV-1 envelope trimer.
Nature communications Feb, 2022 | Pubmed ID: 35136084
Harald Hartweger1,
Rajeev Gautam2,
Yoshiaki Nishimura2,
Fabian Schmidt3,5,
Kai-Hui Yao1,
Amelia Escolano1,6,
Mila Jankovic1,
Malcolm A. Martin2,
Michel C. Nussenzweig1,4
1Laboratory of Molecular Immunology, The Rockefeller University,
2Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health,
3Laboratory of Retrovirology, The Rockefeller University,
4Howard Hughes Medical Institute, The Rockefeller University,
5Laboratory of Applied Virology and Precision Medicine, King Abdullah University of Science and Technology (KAUST),
6Vaccine and Immunotherapy Center, Wistar Institute
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados